Carpal Rx Myofascial Massager Sales Top 50,000 Units Worldwide
Ms. Nicole Zanakis, CEO of Carpal Pain Solutions, Inc., manufacturer and distributor of the patented Carpal Rx myofascial release massager for carpal tunnel syndrome announced a company milestone: the sale of 50,000 Carpal Rx units worldwide since the company began online retail sales in 2013.
"Over the past few years, most of our sales have come from the USA," said Ms. Zanakis. "But in the last12 months, we've seen a huge jump in international sales."
Currently, international sales represent 20% of the company's business. Ms. Zanakis projects that by the start of 2016, nearly 40% of the company's Carpal Rx sales will be from outside the USA. The top countries currently buying the Carpal Rx are Canada, the UK, Australia, Japan, Singapore, Spain, Belgium, the Philippines, Saudi Arabia, the UAE, Mexico, and Brazil. Other Asia-Pacific, South American and European countries round out Carpal Rx foreign sales.
"If the trend continues", Ms. Zanakis said, "By the third quarter of 2017, foreign sales will equal US sales."
The strong worldwide interest in the Carpal Rx stems from the huge jump in the incidence of carpal tunnel syndrome, and the ability of the Carpal Rx to cure its symptoms completely. The Carpal Rx technology is actually very unique; it gives your wrist a therapy known as myofascial release massage. This has long been known to be the best treatment for carpal tunnel syndrome and wrist tendonitis. In fact, it's the only known and established treatment that actually works to relieve symptoms.
Until the Carpal Rx came along, the major downside of myofascial release massage was that you had to visit a therapist every single day (for about a month) to get this treatment. The uniqueness of the Carpal Rx is that it gives you the same massage automatically and at home, so you don't have to visit a therapist daily for the same treatment.
Dr. Antonio Senzi, a Carpal Rx clinical researcher in Italy said, "Prior to [the Carpal Rx] most patients had to either endure their hand pain or have carpal tunnel surgery. But surgery was successful only half of the time. The Carpal Rx is 100% successful, and is a fraction of surgery's cost. Clearly, it's the only viable option for patients."
Echoing Dr. Senzi's remarks, the neurophysiologist and leading expert on the Carpal Rx technology, Dr. Michael Politis added, "Carpal Rx is a game changer in medical therapeutics. We've known that getting myofascial release massage was the only real method of treating carpal tunnel syndrome. But few patients could afford having that treatment professionally done every day. The Carpal Rx does it for you."
In the past two years, various papers and research studies have been presented at international conferences and published in leading medical journals showing the effectiveness of the Carpal Rx technology. More and more independent studies are being published and presented as increasingly greater numbers of physicians and therapists are advising their patients of this treatment.
Ms. Zanakis said, "Since the Carpal Rx provides complete effectiveness and has no risks whatsoever, it's just a matter of time before it enters the worldwide public consciousness as the only real therapy for carpal tunnel syndrome." And with worldwide sales of the Carpal Rx expanding so rapidly, it looks as if that process is well under way.
Carpal Pain Solutions, Inc. is an accredited member of the United States Association of Accredited Business.
Carpal Pain Solutions, Inc.